Tagraxofusp and low-intensity chemotherapy for the treatment of CD123-positive relapsed or refractory acute myeloid leukemia.

Authors: Wooin Cho, Ritika Dutta, Veronica de Santiago, Kyle Denzel Cobarrubias, Jihyun Choi, Emily Bianca Inlow, Blake Shaw, Kristen Cunanan, Vivek Charu, Asiri Ediriwickrema, Tian Yi Zhang, Gabriel N. Mannis

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps6582

Source: Full article

---

Abstract

TPS6582